42 results on '"Kostopoulou, Myrto"'
Search Results
2. Lupus Nephritis: Improving Treatment Options
3. Clinical and Laboratory Profile of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD): PUB186
4. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
5. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
6. Prevention and treatment of childhood and adolescent obesity: a systematic review of meta-analyses
7. Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxis
8. Annals of the Rheumatic Diseases collection on lupus nephritis (2019–2022): novel insights and advances in therapy
9. An Update on the Diagnosis and Management of Lupus Nephritis
10. MO008: Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) without a Clear Family History have Rapid Progression and Poor Prognosis
11. MO216: The Importance of Nephrotic Range Proteinuria in Renal Survival of Patients With IGA Nephropathy
12. MO007: Clinical and Laboratory Profile of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
13. MO222: Prognostic Factors for CKD Progression in Patients with IGA Nephropathy
14. MO010: Parameters Associated with Progression, Prognosis and Tolvaptan Indication in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
15. Trends in Mortality Due to Myocardial Infarction, Stroke, and Pulmonary Embolism in Patients Receiving Dialysis
16. sj-pdf-1-lup-10.1177_09612033221074580 ��� Supplemental Material for The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus
17. sj-pdf-2-lup-10.1177_09612033221074580 ��� Supplemental Material for The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus
18. The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus
19. Treatment of lupus: more options after a long wait
20. Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients
21. Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations
22. Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention
23. Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations
24. P0040BASELINE CHARACTERISTICS AND ASSOCIATIONS WITH RENAL FUNCTION IN A GREEK COHORT OF POLYCYSTIC KIDNEY DISEASE
25. P0034IDENTIFICATION OF FACTORS ASSOCIATED WITH PROGRESSION, PROGNOSIS AND TOLVAPTAN INDICATION IN POLYCYSTIC KIDNEY DISEASE PATIENTS
26. Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease
27. 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
28. P150 The evolving clinical presentation of systemic lupus erythematosus in a newly established caucasian cohort: low incidence of lupus nephritis and high burden of neuropsychiatric disease
29. 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
30. A SYSTEMATIC LITERATURE REVIEW TO INFORM THE 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
31. Hereditary systemic amyloidosis caused by K19T apolipoprotein C-II variant
32. Access to kidney transplantation in European adults aged 75 to 84 years and related outcomes: An analysis of the ERA-EDTA Registry database
33. FRI0192 A SYSTEMATIC LITERATURE REVIEW TO INFORM THE 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
34. SP498IMPACT OF DIALYSATE MAGNESIUM ON ALL CAUSE MORTALITY IN PERITONEAL DIALYSIS PATIENTS
35. FRI0193 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
36. THU0254 TRENDS OF SEVERITY, PROGRESSION AND BURDEN OF DISEASE IN THE “ATTIKON” SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) COHORT: EVIDENCE FOR THE RULE OF “ONE THIRD” IN DISEASE SEVERITY
37. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
38. Hereditary systemic amyloidosis caused by K19T apolipoprotein C-II variant
39. Access to kidney transplantation in European adults aged 75-84 years and related outcomes: an analysis of the European Renal Association-European Dialysis and Transplant Association Registry
40. MP577HIGH SERUM MAGNESIUM LEVELS AND CINACALCET USE ARE ASSOCIATED WITH LOWER ABDOMINAL AORTIC CALCIFICATION SCORES IN PERITONEAL DIALYSIS PATIENTS
41. Reducing Diagnostic Errors -- Recognizing Monoclonal Gammopathy of Renal Significance (MGRS).
42. Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis et al .
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.